T/CMEAS 003-2023 Active Group standards

T/CMEAS 003-2023 The anesthesia treatment of patients with severe and critical COVID-19

T/CMEAS 003-2023 The anesthesia treatment of patients with severe and critical COVID-19

Publish Date: 2023-03-14 Implement Date: 2023-03-14 For services related to genuine standard inquiry, procurement, translation, and other related services in China, please Contact Us
Price: $ 20.00
Out of stock

Basic Information

Standard Code: T/CMEAS 003-2023
Standard Type: Group standards
Standard Status: Active
is_force_gb: no
CCS Name: -
ICS Name: Integrated medical science and healthcare devices
Publish Date: 2023-03-14
Implement Date: 2023-03-14

Scope

Main technical content: This document specifies the basic equipment, medications, and medical supplies required for anesthesia and treatment of patients with severe and critical cases of novel coronavirus infection, including basic monitoring, establishment of intravenous access, tracheal intubation, mechanical ventilation, precise management of ideal anesthesia state, regulation of pulmonary microcirculation function, volume management and fluid therapy, as well as special monitoring and examination during anesthesia and treatment. This document is applicable to patients with severe and critical cases of novel coronavirus infection who have poor outcomes from non-invasive respiratory therapy and require invasive mechanical ventilation respiratory support, as well as patients who receive anesthesia treatment from the anesthesiology department according to the requirements of the "Treatment Protocol for Severe Cases of Novel Coronavirus Infection" (Trial Version 4) and the "Treatment Protocol for Novel Coronavirus Infection" (Trial Version 10). Other symptomatic treatment protocols refer to the content of the "Treatment Protocol for Severe Cases of Novel Coronavirus Infection" (Trial Version 4) and the "Treatment Protocol for Novel Coronavirus Infection" (Trial Version 10).

Development Information

Related Standards

Contact Us